Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.55 |
| ▸ | HRH4 | Q9H3N8 | 10/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28265781 | 0.91 | ALDH1A1 (0.46) | TLR8HRH4ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL28265742 | 0.90 | TLR8 (0.46) | TLR8HRH4ALDH1A1MAPK14KMT2A | |
| SCHEMBL28265690 | 0.90 | MAPT (0.45) | TLR8HRH4ALDH1A1LMNAPKM | |
| SCHEMBL28265699 | 0.89 | MAPK14 (0.46) | TLR8HRH4ALDH1A1MAPK14KMT2A | |
| SCHEMBL28265753 | 0.88 | TLR8 (0.46) | TLR8HRH4ALDH1A1SMN1; SMN2 | |
| SCHEMBL28267606 | 0.87 | TLR8 (0.49) | TLR8HRH4 | |
| SCHEMBL28265859 | 0.86 | TLR8 (0.43) | TLR8HRH4ALDH1A1PKMKDM4E | |
| SCHEMBL28267608 | 0.85 | TLR8 (0.50) | TLR8HRH4ALDH1A1 | |
| SCHEMBL28267602 | 0.84 | HRH4 (0.47) | TLR8HRH4ALDH1A1SMN1; SMN2 | |
| SCHEMBL28043719 | 0.84 | HRH4 (0.55) | TLR8HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105143206-B | Pyrimidine -2,4- diamine derivative for treating cancer | 托马斯·黑勒戴药物研究基金会 | 2019-01-15 | — | — | CN | claimed |
| CN-105143206-B | Pyrimidine -2,4- diamine derivative for treating cancer | 托马斯·黑勒戴药物研究基金会 | 2019-01-15 | — | — | CN | disclosed |